InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast featuring Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp.
March 12, 2021 08:17 ET
|
InvestorBrandNetwork (IBN)
LOS ANGELES, March 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment...
Aegis Sciences Corporation and Walgreens announce expansion of COVID-19 diagnostic testing
February 11, 2021 08:00 ET
|
Aegis Sciences Corporation
NASHVILLE, Tenn. and DEERFIELD, Ill., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and...
FluroTech Announces Appointment of Regulatory Consultant
January 14, 2021 08:45 ET
|
FluroTech Ltd.
CALGARY, Alberta, Jan. 14, 2021 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), is pleased to announce it has retained PandiaDx LLC (“PandiaDX”) for...
FluroTech Announces Closing of First Tranche of Private Placement
January 11, 2021 08:45 ET
|
FluroTech Ltd.
CALGARY, Alberta, Jan. 11, 2021 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), is very pleased to announce that it has closed the first tranche of a...
FluroTech Announces Exploration of Strategic Options for Cannabis Testing Business to Focus on Pandemic Defense System
December 18, 2020 18:00 ET
|
FluroTech Ltd.
CALGARY, Alberta, Dec. 18, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is exploring strategic alternatives for its Cannabis and Hemp testing...
FluroTech Announces Stadium and Arena Product Solution
November 17, 2020 08:00 ET
|
FluroTech Ltd.
CALGARY, Alberta, Nov. 17, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that (“FluroTest”) will launch its first product...
FluroTech Announces Joint Venture SARS-CoV2 Test Method Optimization
November 12, 2020 09:00 ET
|
FluroTech Ltd.
CALGARY, Alberta, Nov. 12, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that has begun optimization of its SARS-CoV2...
FluroTech Announces Joint Venture Product Solution and Partners
November 10, 2020 08:45 ET
|
FluroTech Ltd.
CALGARY, Alberta, Nov. 10, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce, its previously announced joint venture...
FluroTech Formalizes Ownership Structure in FluroTest Joint Venture and Launches a Financing
November 05, 2020 08:45 ET
|
FluroTech Ltd.
CALGARY, Alberta, Nov. 05, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that FluroTest, LLC (the “LLC”), a company in...
FluroTech Announces Filing of Patent Applications With Respect to Its Proprietary Diagnostic Test Method and Pandemic Defense Platform
October 22, 2020 09:04 ET
|
FluroTech Ltd.
CALGARY, Alberta, Oct. 22, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that FluroTest LLC (“FluroTest”), a company in...